Pfizer integrated symposium
at ECCMID 2024 now available
on demand |
For healthcare professionals only.
Pfizer was pleased to support the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). In case you missed the live symposium ‘COVID-19: are we meeting the challenge?’, this is now available to watch on demand via the ECCMID 2024 platform!
COVID-19: are we meeting the challenge?
As we progress through the post-pandemic era, it is crucial to continue to assess the burden of COVID-19 and how the infectious disease community can support our vulnerable patients who are still at high risk of progressing to severe disease. Join our global COVID-19 experts as they use the latest COVID-19 data, insights and perspectives to discuss whether the challenge of COVID-19 on a global level is being met.
|
|
|
|
Organiser-appointed Chair
Dr Roger Paredes, MD, PhD
Hospital Germans Trias i Pujol and IrsiCaixa AIDS Research Institute, Badalona, Catalonia, Spain
|
|
|
|
ESCMID-appointed Chair
Professor Sylvie van der Werf, PhD
Virology Department, Institute Pasteur, Paris, France
|
|
|
|
Dr Juleen Gayed, MBBS, MSC, FFPM
Vaccine Clinical Research and Development, Pfizer, London, UK
|
|
|
|
Dr Ziyad Al-Aly, MD
Veterans Affairs Saint Louis Health Care System, Saint Louis, Missouri, USA
|
|
|
|
Dr Luke Moore, FRCPath, FRCP, PhD, MPH, MSc, DTM&H, DipEd, FHEA, MBChB
Chelsea & Westminster NHS Foundation Trust, Imperial College Healthcare NHS Trust, and Imperial College London, London, UK
|
|
|
|
Professor Dominique Salmon, MD, PhD
Fournier Institute, Assistance Publique Hôpitaux de Paris, High Authority of Health, University of Paris Cité, Paris, France
|
|
|
|
Dr Romina Quercia, MD, PhD, MGH
Pfizer, and Research Unit, Royal Chelsea Hospital, London, UK
|
|
|
Thank you for joining us at ECCMID 2024
We hope to see you again next year
|
|
|
This symposium is initiated, organised and funded by Pfizer Inc.
©2024 Pfizer Inc. All rights reserved.
PP-C1D-GLB-0077; Date of Preparation: April 2024.
|
|
|
|
